GOSS

Gossamer Bio Stock Analysis

AI Rating

Fair
  • Quality7/10
  • Growth↓ 0/10
  • Momentum↑ 6/10
Gossamer Bio sales and earnings growth
GOSS Growth
Low
  • Revenue Y/Y↓ -58.17%
  • EPS Y/Y↓ -165.38%
  • FCF Y/Y↓ -11134.02%
Gossamer Bio gross and profit margin trends
GOSS Profitability
Low
  • Gross margin ↑ 100.00%
  • EPS margin↓ -354.50%
  • ROIC↓ -38.50%
Gossamer Bio net debt vs free cash flow
GOSS Risk
Great
  • Debt / Equity↓ -2.5
  • Debt / FCF↓ 1.2
  • Interest coverage↓ -13.4

Gossamer Bio stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗